An electron microscope image of the Covid-19 virus. Photo: Handout via AP
An electron microscope image of the Covid-19 virus. Photo: Handout via AP

China may approve first Covid-19 drug within weeks

  • Monoclonal antibody treatment developed by Chinese and US researchers might get conditional approval by year-end, science and technology ministry daily says
  • Sinopharm subsidiary meanwhile is readying clinical trials for both human and lab-made antibody treatments

Topic |   Coronavirus pandemic
An electron microscope image of the Covid-19 virus. Photo: Handout via AP
An electron microscope image of the Covid-19 virus. Photo: Handout via AP

Corrected [1:28pm, 17 Nov, 2021]

  • [1:28pm, 17 Nov, 2021]

    An earlier version of this story incorrectly reported that Brii Bio was seeking conditional approval for its drug in China. The story has been amended to reflect that a company spokeswoman did not specify what kind of approval was sought.

  • We are part of the Trust Project What is it?
READ FULL ARTICLE